Personalised healthcare management firm Qinec has secured £6m in Series B funding, led by Gilde Healthcare Partners, and including existing investors Amadeus Capital Partners and Archimedia.

Qinec personalises the delivery of healthcare, by using real-time data to orchestrate the patient journey resulting in optimal outcomes for patients, providers and payers whilst simultaneously reducing cost.

Its cloud-based personalised healthcare management platform currently supports millions of patient journeys a year across Europe.

Qinec will use the funding to scale the team and further expand the business to take advantage of a market predicted to be worth over $1.3bn.

This will enable the company, which counts Alliance Medical and Optegra Eye Health Care as customers, to grow more aggressively within the healthcare IT market.

Robbie Hughes, CEO and founder of Qinec, said: “Whilst every clinician would intuitively recognise that healthcare should be a personalised experience, delivering personalisation at scale has been impossible to date with different systems and stakeholders owning different parts of the patient journey.

“Qinec looks at the problem differently, providing a single platform to join up pathways across specialties and systems, giving visibility and control to providers.”

As part of the investment, Janke Dittmer, partner at Gilde Healthcare, joins the Board as a non-executive director and Erik Masing as an advisor.

Additionally, Qinec is strengthening its executive team with the introduction of Andrew Wyatt as chief operating officer. Wyatt brings a depth of experience in successfully scaling software and SaaS businesses, including BroadSoft Inc where he was VP strategy and Apertio Ltd where he was chief product operations officer and interim CEO.

Show Comments